Hatch Hearing Turns Up Few New Deficiencies In NCI Contract Management; DeVita Blasted On Strauss
In Brief: NCAB Approves Concept Of Converting Baltimore Program To Cancer Center; New DCCP Labs Named
NCAB Okays New System For Bypass Budget; FY 1983 Request $1.096 Billion DCCP Board Approves Payback System For Resources Now Free
Chemoprevention, Immunotoxicolgy RFAs Available
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”
